Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $11.02B | $9.87B | +11.66% |
Cost of Revenue | $1.53B | $1.26B | +21.26% |
Operating Income | $-232.9M | $3.83B | -106.08% |
Net Income | $-535.6M | $3.62B | -114.80% |
EPS (Basic) | $-2.08 | $14.05 | -114.80% |
EPS (Diluted) | $-2.08 | $13.89 | -114.97% |
SG&A Expense | $1.46B | $1.14B | +28.83% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $22.53B | $22.73B | -0.87% |
Current Assets | $9.6B | $14.14B | -32.15% |
Total Liabilities | $6.12B | $5.15B | +18.91% |
Current Liabilities | $3.56B | $3.55B | +0.48% |
Stockholders' Equity | $16.41B | $17.58B | -6.66% |
Cash & Equivalents | $4.57B | $10.37B | -55.93% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-492.6M | $3.54B | -113.93% |
Investing Cash Flow | $-3.77B | $-3.14B | -20.00% |
Financing Cash Flow | $-1.49B | $-562.2M | -165.90% |
Share Buybacks | $1.18B | $427.6M | +175.28% |
D&A | $207.2M | $181.3M | +14.29% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -2.1% | 38.8% | -40.94% |
Net Margin | -4.9% | — | — |
ROE | -3.3% | — | — |
ROA | -2.4% | — | — |
Current Ratio | $2.692 | — | — |
Debt to Equity | $0.373 | — | — |
Other companies in Biotechnology